2-Chloro-5-(morpholinosulfonyl)benzoic acid

Catalog No. :
ACIBFP173
CAS No. :
109029-96-1
Molecular Formula :
C11H12ClNO5S
Molecular Weight :
305.74

IUPAC Name:2-chloro-5-(morpholinosulfonyl)benzoic acid

2-Chloro-5-(morpholinosulfonyl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$165.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-5-(morpholinosulfonyl)benzoic acid
IUPAC Name2-chloro-5-(morpholinosulfonyl)benzoic acid
MDL No.MFCD00492872
Molecular FormulaC11H12ClNO5S
Molecular Weight305.74
SMILESO=C(O)C1=CC(S(=O)(N2CCOCC2)=O)=CC=C1Cl
InChI KeyGOWHUHLKBKFDKK-UHFFFAOYSA-N
SynonymOTAVA-BB BB7020410135;2-CHLORO-5-(MORPHOLINE-4-SULFONYL)-BENZOIC ACID;Benzoic acid, 2-chloro-5-(4-morpholinylsulfonyl)-;2-Chloro-5-(4-morpholinylsulfonyl)benzoic acid;2-Chloro-5-(morpholin-4-ylsulfonyl)-benzoic acid;2-chloro-5-(morpholinosulfonyl)benzoic acid
CAS No.109029-96-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIBFP173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIBFP173 route product structure diagram
    ACIBFP173109029-96-1 In Stock
Inquiry

2. ACIBFP173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACIBFP173 route product structure diagram
    ACIBFP173109029-96-1 In Stock
Inquiry

Comments (0)